Özlem Koşar Can
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Özlem Koşar Can has a total of 329 co-authors. Here are the top co-authors by number of shared publications:
- Cihan Kabukçu
Department of Obstetrics and Gynecology, School of Medicine, Pamukkale University, Denizli, Türkiye
4 shared publications - Ümit Çabuş
Department of Obstetrics and Gynecology, School of Medicine, Pamukkale University, Denizli, Türkiye
4 shared publications - Mine Islimye Taskin
Department of Obstetrics & Gynecology, Faculty of Medicine, Balıkesir University, 10020 Balıkesir, Turkey
2 shared publications - Semin Melahat Fenkci
Department of Endocrinology and Metabolism, Faculty of Medicine, Pamukkale University
2 shared publications - Soner Gök
Pamukkale Universitesi
2 shared publications - Yaşar Enli
Pamukkale Universitesi Tıp Fakultesi
2 shared publications
Latest Publications
- Open Access
- 3 September 2025
- Published by Bentham Science Publishers Ltd. in Current Medical Imaging
- Vol. 21, 1-7
Evaluating Cerebral Blood Flow among Patients Experiencing Premenstrual Syndrome with Headache using Duplex Ultrasonography
Introduction: This study aimed to demonstrate the relationship between hemodynamic changes in head blood flow and headache during the premenstrual period in patients experiencing premenstrual syndrome. Methods: Thirty-two female patients experiencing premenstrual headaches were prospectively examined using carotid and vertebral artery duplex ultrasonography during headache episodes in the premenstrual periods and headache-free periods across two consecutive menstrual cycles. The diameters and areas of both the carotid and vertebral arteries, along with systolic and end-diastolic velocities, pulsatility and resistivity indices, and volumetric flow rates, were measured using grayscale imaging. Total head blood flow was determined as the sum of bilateral common carotid artery and vertebral artery flow volumes. Measurements were compared between participants’ premenstrual and menstrual periods. Results: A statistically significant difference in the diameter of the left external carotid artery was observed between periods with and without headache during the two consecutive menstrual cycles assessed (p = 0.030). Left external carotid artery (p = 0.019), total external carotid artery (p = 0.028), and total head blood volumes (p = 0.030) were significantly higher when headache was present during the premenstrual period than when headache was absent. Discussion: Towards the end of the luteal phase, the total head blood flow and external carotid artery flow were high due to a decrease in peripheral resistance caused by the decline in progesterone and hormonal fluctuations during this period. Conclusion: Increased flow volume in the external carotid arteries and total head blood flow may be a contributing factor to premenstrual headaches.
- 3 September 2025
- Published by Bentham Science Publishers Ltd. in Current Medical Imaging
- Vol. 21, 1-7
Open AccessEvaluating Cerebral Blood Flow among Patients Experiencing Premenstrual Syndrome with Headache using Duplex Ultrasonography
Introduction: This study aimed to demonstrate the relationship between hemodynamic changes in head blood flow and headache during the premenstrual period in patients experiencing premenstrual syndrome. Methods: Thirty-two female patients experiencing premenstrual headaches were prospectively examined using carotid and vertebral artery duplex ultrasonography during headache episodes in the premenstrual periods and headache-free periods across two consecutive menstrual cycles. The diameters and areas of both the carotid and vertebral arteries, along with systolic and end-diastolic velocities, pulsatility and resistivity indices, and volumetric flow rates, were measured using grayscale imaging. Total head blood flow was determined as the sum of bilateral common carotid artery and vertebral artery flow volumes. Measurements were compared between participants’ premenstrual and menstrual periods. Results: A statistically significant difference in the diameter of the left external carotid artery was observed between periods with and without headache during the two consecutive menstrual cycles assessed (p = 0.030). Left external carotid artery (p = 0.019), total external carotid artery (p = 0.028), and total head blood volumes (p = 0.030) were significantly higher when headache was present during the premenstrual period than when headache was absent. Discussion: Towards the end of the luteal phase, the total head blood flow and external carotid artery flow were high due to a decrease in peripheral resistance caused by the decline in progesterone and hormonal fluctuations during this period. Conclusion: Increased flow volume in the external carotid arteries and total head blood flow may be a contributing factor to premenstrual headaches.
- 7 July 2025
- Published by Wiley in Nutrition Bulletin
- Vol. 50 (3) , 436-446
Associations Between Maternal Vitamin B12 Levels, Sociodemographic Factors and Placental Weight: A Cross‐Sectional Analysis in a Tertiary Hospital
This study aimed to investigate whether serum vitamin B12 concentration is associated with placental weight and maternal sociodemographic characteristics in pregnant women who delivered in a tertiary hospital. A total of 497 pregnant women with a single foetus who had achieved 37 weeks gestational age were included in this cross‐sectional study. All pregnant women were evaluated via a questionnaire about nutrition and dietary habits, weight gain during pregnancy, antenatal multivitamin supplementation and sociodemographic features. The serum vitamin B12 levels were measured in pregnant women, and their placentas were weighed immediately after delivery. Vitamin B12 deficiency was observed in about 79.5% of pregnant women, despite 63% of participants reporting the use of antenatal multivitamin supplements. Household economic status and pre‐pregnancy body mass index (BMI) were identified as significant factors associated with maternal vitamin B12 levels. Furthermore, household economic status and maternal age were found to be significant factors associated with placental weight. This study identified a high prevalence of vitamin B12 deficiency among pregnant women with low family incomes. Moreover, it revealed a relationship between placental weight and household economic status. The findings also highlight that despite a relatively high rate of antenatal multivitamin supplementation, vitamin B12 deficiency remains a critical issue. No statistically significant relationship between placental weight and serum vitamin B12 concentration has been detected. Further large‐scale and prospective studies are needed to establish the effect of maternal vitamin B12 levels on placental weight.
- 7 July 2025
- Published by Wiley in Nutrition Bulletin
- Vol. 50 (3) , 436-446
Associations Between Maternal Vitamin B12 Levels, Sociodemographic Factors and Placental Weight: A Cross‐Sectional Analysis in a Tertiary Hospital
This study aimed to investigate whether serum vitamin B12 concentration is associated with placental weight and maternal sociodemographic characteristics in pregnant women who delivered in a tertiary hospital. A total of 497 pregnant women with a single foetus who had achieved 37 weeks gestational age were included in this cross‐sectional study. All pregnant women were evaluated via a questionnaire about nutrition and dietary habits, weight gain during pregnancy, antenatal multivitamin supplementation and sociodemographic features. The serum vitamin B12 levels were measured in pregnant women, and their placentas were weighed immediately after delivery. Vitamin B12 deficiency was observed in about 79.5% of pregnant women, despite 63% of participants reporting the use of antenatal multivitamin supplements. Household economic status and pre‐pregnancy body mass index (BMI) were identified as significant factors associated with maternal vitamin B12 levels. Furthermore, household economic status and maternal age were found to be significant factors associated with placental weight. This study identified a high prevalence of vitamin B12 deficiency among pregnant women with low family incomes. Moreover, it revealed a relationship between placental weight and household economic status. The findings also highlight that despite a relatively high rate of antenatal multivitamin supplementation, vitamin B12 deficiency remains a critical issue. No statistically significant relationship between placental weight and serum vitamin B12 concentration has been detected. Further large‐scale and prospective studies are needed to establish the effect of maternal vitamin B12 levels on placental weight.
- Open Access
- 23 June 2025
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 52 (6)
Variations in Calcitonin Gene-Related Peptide, Adiponectin, and Ghrelin Levels and Their Effects on Preeclampsia
Background: This study aimed to investigate serum levels of calcitonin gene-related peptide (CGRP) and explore potential associations between serum CGRP, adiponectin, and ghrelin concentrations in patients with preeclampsia. Methods: This study evaluated 43 normotensive healthy pregnant women and 36 pregnant women diagnosed with preeclampsia. Serum concentrations of CGRP, adiponectin, and ghrelin were measured in both groups during the third trimester of pregnancy. Results: Serum concentrations of CGRP were significantly elevated in the preeclampsia group compared to the control group. Conversely, the preeclampsia group exhibited significantly decreased serum levels of adiponectin and ghrelin relative to the controls. No significant correlation was observed between serum CGRP levels and adiponectin or ghrelin levels in either the preeclampsia or control groups. Conclusions: Our study demonstrates a considerable increase in serum CGRP concentrations in patients with preeclampsia compared to the control group. These outcomes strongly indicate that CGRP may play a pivotal role in the pathogenesis of preeclampsia.
- 23 June 2025
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 52 (6)
Open AccessVariations in Calcitonin Gene-Related Peptide, Adiponectin, and Ghrelin Levels and Their Effects on Preeclampsia
Background: This study aimed to investigate serum levels of calcitonin gene-related peptide (CGRP) and explore potential associations between serum CGRP, adiponectin, and ghrelin concentrations in patients with preeclampsia. Methods: This study evaluated 43 normotensive healthy pregnant women and 36 pregnant women diagnosed with preeclampsia. Serum concentrations of CGRP, adiponectin, and ghrelin were measured in both groups during the third trimester of pregnancy. Results: Serum concentrations of CGRP were significantly elevated in the preeclampsia group compared to the control group. Conversely, the preeclampsia group exhibited significantly decreased serum levels of adiponectin and ghrelin relative to the controls. No significant correlation was observed between serum CGRP levels and adiponectin or ghrelin levels in either the preeclampsia or control groups. Conclusions: Our study demonstrates a considerable increase in serum CGRP concentrations in patients with preeclampsia compared to the control group. These outcomes strongly indicate that CGRP may play a pivotal role in the pathogenesis of preeclampsia.
- 21 January 2025
- Published by Academician Publishing
- p. 221-230
Endometrioma İlişkili İnfertilite Yönetimi
- 21 January 2025
- Published by Academician Publishing
- p. 221-230
Endometrioma İlişkili İnfertilite Yönetimi
- Open Access
- 1 January 2025
- Published by Pamukkale University in Pamukkale Medical Journal
- Vol. 18 (3) , 530-539
Association of PTEN expression with hormone receptor status, tumor subtype, histological grade, and clinicopathological parameters in endometrial carcinomas
Purpose: This study investigates the relationship between PTEN expression and tumor characteristics and clinical outcomes in endometrial carcinoma (EC). EC is the most common malignancy of the female genital tract, typically classified into Type I (endometrioid, hormone-sensitive, favorable prognosis) and Type II (serous, aggressive, poor prognosis). PTEN is a tumor suppressor gene that regulates cell growth. Loss of PTEN expression is frequently observed in Type I EC and is associated with early tumorigenesis. Materials and methods: A retrospective analysis was conducted on 186 EC cases. PTEN expression was evaluated immunohistochemically, and its association with tumor size, histological subtype, stage, hormone receptor status, and survival outcomes was analyzed. Results: Loss of PTEN expression was detected in 81.2% of cases. While PTEN loss was more prevalent in tumors >3 cm in size, it did not show a significant correlation with stage, grading, myometrial invasion, or metastasis. p53 mutation and high-grade tumors were associated with poorer survival rates. Estrogen receptor (ER) and progesterone receptor (PR) expression were predominantly observed in endometrioid carcinoma. Conclusions: Although PTEN loss is frequently observed in endometrioid EC, it does not directly impact survival outcomes. Hormone receptor status and genetic alterations play a crucial role in EC pathogenesis. Further studies on PTEN and other molecular markers may contribute to the development of personalized treatment strategies. These findings suggest that while PTEN loss plays a role in early tumor development, it is not a definitive prognostic factor in EC.
- 1 January 2025
- Published by Pamukkale University in Pamukkale Medical Journal
- Vol. 18 (3) , 530-539
Open AccessAssociation of PTEN expression with hormone receptor status, tumor subtype, histological grade, and clinicopathological parameters in endometrial carcinomas
Purpose: This study investigates the relationship between PTEN expression and tumor characteristics and clinical outcomes in endometrial carcinoma (EC). EC is the most common malignancy of the female genital tract, typically classified into Type I (endometrioid, hormone-sensitive, favorable prognosis) and Type II (serous, aggressive, poor prognosis). PTEN is a tumor suppressor gene that regulates cell growth. Loss of PTEN expression is frequently observed in Type I EC and is associated with early tumorigenesis. Materials and methods: A retrospective analysis was conducted on 186 EC cases. PTEN expression was evaluated immunohistochemically, and its association with tumor size, histological subtype, stage, hormone receptor status, and survival outcomes was analyzed. Results: Loss of PTEN expression was detected in 81.2% of cases. While PTEN loss was more prevalent in tumors >3 cm in size, it did not show a significant correlation with stage, grading, myometrial invasion, or metastasis. p53 mutation and high-grade tumors were associated with poorer survival rates. Estrogen receptor (ER) and progesterone receptor (PR) expression were predominantly observed in endometrioid carcinoma. Conclusions: Although PTEN loss is frequently observed in endometrioid EC, it does not directly impact survival outcomes. Hormone receptor status and genetic alterations play a crucial role in EC pathogenesis. Further studies on PTEN and other molecular markers may contribute to the development of personalized treatment strategies. These findings suggest that while PTEN loss plays a role in early tumor development, it is not a definitive prognostic factor in EC.
- RetractionOpen Access
- 17 August 2023
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 308 (5) , 1661
Retraction Note: Luteal phase clomiphene citrate for ovulation induction in women with polycystic ovary syndrome
- 17 August 2023
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 308 (5) , 1661
RetractionOpen AccessRetraction Note: Luteal phase clomiphene citrate for ovulation induction in women with polycystic ovary syndrome
- 30 January 2023
- Published by Springer Nature in Reproductive Sciences
- Vol. 30 (7) , 2198-2209
Long-Term Follow-Up Result of Connective Tissue Manipulation in Young Women with Primary Dysmenorrhea: Different Intervention Durations
The purpose of this study was to reveal the effect of connective tissue manipulation (CTM) on long-term pain severity, fatigue, sleep quality, premenstrual
- 30 January 2023
- Published by Springer Nature in Reproductive Sciences
- Vol. 30 (7) , 2198-2209
Long-Term Follow-Up Result of Connective Tissue Manipulation in Young Women with Primary Dysmenorrhea: Different Intervention Durations
The purpose of this study was to reveal the effect of connective tissue manipulation (CTM) on long-term pain severity, fatigue, sleep quality, premenstrual
- Open Access
- 8 March 2022
- Published by Galenos Yayinevi in Journal of the Turkish-German Gynecological Association
- Vol. 23 (1) , 28-32
Retrospective clinical evaluation of indications for termination of pregnancies due to fetal anomaly
To assess the indications for termination of pregnancy (TOP) in pregnant patients who were followed up with suspicion of fetal anomaly in a Turkish tertiary referral center. This retrospective study was carried out in patients who were followed up with suspicion of fetal anomaly between May 2016 and May 2019 at the Perinatology Clinic of Obstetrics and Gynecology Department in Pamukkale University Hospital, which is a tertiary hospital in Denizli province in Turkey. Women were divided into two depending on gestational period: group 1 ≤22 weeks; and group 2 (>23 weeks of gestation). Four hundred and seventeen pregnant women were evaluated and TOP was performed at a mean gestational age of 27.7±6.3 weeks. There were 308 (73.8%) women in group 1 and 109 (26.2%) in group 2. The decision to terminate pregnancy was due to fetal anomaly in 117 (28.1%). The majority of termination pregnancies in group 2 were performed because of multiple malformations and/or central nervous system defects. All chromosomal diseases were detected in group 1. With a good perinatal screening program, fetal anomalies can be diagnosed early. Therefore, early TOP is possible. Thus, pregnancy termination can be made before reaching the life limit.
- 8 March 2022
- Published by Galenos Yayinevi in Journal of the Turkish-German Gynecological Association
- Vol. 23 (1) , 28-32
Open AccessRetrospective clinical evaluation of indications for termination of pregnancies due to fetal anomaly
To assess the indications for termination of pregnancy (TOP) in pregnant patients who were followed up with suspicion of fetal anomaly in a Turkish tertiary referral center. This retrospective study was carried out in patients who were followed up with suspicion of fetal anomaly between May 2016 and May 2019 at the Perinatology Clinic of Obstetrics and Gynecology Department in Pamukkale University Hospital, which is a tertiary hospital in Denizli province in Turkey. Women were divided into two depending on gestational period: group 1 ≤22 weeks; and group 2 (>23 weeks of gestation). Four hundred and seventeen pregnant women were evaluated and TOP was performed at a mean gestational age of 27.7±6.3 weeks. There were 308 (73.8%) women in group 1 and 109 (26.2%) in group 2. The decision to terminate pregnancy was due to fetal anomaly in 117 (28.1%). The majority of termination pregnancies in group 2 were performed because of multiple malformations and/or central nervous system defects. All chromosomal diseases were detected in group 1. With a good perinatal screening program, fetal anomalies can be diagnosed early. Therefore, early TOP is possible. Thus, pregnancy termination can be made before reaching the life limit.
- 5 March 2022
- Published by Academician Publishing
Temel Kadın Hastalıkları ve Doğum Bilgisi